Accordingly, another report demonstrated that combined p53 and MYC defects emerge at MB recurrence and that relapsed SHH MB with altered p53/MYC were significantly associated with LC/A pathology (47). This evidence concerns the gene TP53 and laryngotracheoesophageal cleft.